History and Overview of the Program in Molecular Medicine
The Program in Molecular Medicine was established in 1989 in the Two Biotech building located within the overall Medical School campus, in the Massachusetts Biotechnology Research Park. Its goal was to attract top academic scientists to meet the challenge of investigating exciting problems in biomedicine in the context of a collaborative culture. Michael Czech, then the Chair of the Department of Biochemistry, was appointed Founding Director of the new Program, moving his laboratory group in 1990 to Two Biotech.
Molecular Medicine was provided control over space on two floors in Two Biotech and financial resources for its operation and faculty recruiting. However, all faculty appointments were made through one of the Medical School departments in this first phase of development.
The strategy for the scientific development of the Program was to assemble outstanding investigators with diverse, but overlapping scientific interests in order to probe molecular mechanisms that underlie physiological processes and the diseases associated with them. These laboratory groups brought a broad spectrum of state-of-the-art methodologies to the Program. Some of the instrumentation and technical capabilities established in Molecular Medicine included X-ray crystallography, nuclear magnetic resonance, digital imaging of single live cells, and the production of transgenic and knockout animals.
The Program in Molecular Medicine initially included several laboratory groups already at the Medical School, and these founding faculty moved into Two Biotech in 1989/1990. Over the next few years the Program recruited additional faculty and expanded to fifteen medical school faculty research groups, affiliated with seven basic science and clinical departments. These included biochemistry and molecular biology, cell biology, medicine, molecular genetics and microbiology, pediatrics, pharmacology and physiology. The Two Biotech building was then purchased by the Medical School and the entire building was eventually allocated to the Program in Molecular Medicine..
Over the years the Program continued to recruit faculty, leading to its current number of twenty one research laboratories within the building. Further recent faculty recruitments and expansion has now included two Molecular Medicine laboratories (Craig Ceol and Jason Kim, also director of the Mouse Phenotyping Center) scheduled to move into the new Sherman Center for research when completed in January 2013.
In 2000, the Program in Molecular Medicine was granted departmental status, with the ability to make academic appointments within its own “department”, although it retained its original name—Program in Molecular Medicine. In addition to the 21 laboratory groups in the Molecular Medicine building, 18 tenured or tenure track faculty in other programs (that do not have departmental status) have primary faculty appointments in Molecular Medicine and attend faculty meetings, retreats, etc. Responsibility for their financial issues and laboratory space remains with their Program Directors. These latter 19 faculty are located in the Program in Gene Function and Expression (PGFE), in the Program in Bioinformatics or in the RNA Therapeutics Institute..
Michael Green, recruited by Czech to Molecular Medicine from Harvard in 1990, was appointed in 2001 founding Director of the new Program in Gene Function and Expression located in the Lazar Research Building. Dr. Green has recruited numerous faculty since that time and many of those faculty in his Program have elected to have their primary faculty appointment in Molecular Medicine. Zhiping Weng, was recruited to UMASS MED in 2008 as Director of the Program in Bioinformatics and has been recruiting faculty to her Program. One of these has elected to join Molecular Medicine as a tenure track faculty member (Manuel Garber). In addition, Craig Peterson, first recruited to Molecular Medicine as an Assistant Professor in 1991 and now Professor, was appointed as Vice Chair of Molecular Medicine in 2004 and continues to serve in this position.
Thus Molecular Medicine now has approximately 40 faculty, in three buildings. These faculty are active in faculty meetings, personnel action deliberations (including tenure decisions), retreats, seminars and journal clubs, recruitments to the Program and social functions. Molecular Medicine sponsors a monthly “in house” seminar program for its own faculty seminars as well as a distinguished lecturer series (now called Pioneers in Molecular Medicine Lectures) for outside speakers. The in house seminars are followed by faculty luncheon meetings in our Boardroom for all tenure or tenured track faculty.
Molecular Medicine accomplishments in research have been recognized by the 2006 Nobel Prize in Physiology or Medicine awarded to Craig Mello (shared with Andrew Fire of Stanford University), the 2008 Lasker Basic Medical Research Award to Victor Ambros (shared with Gary Ruvkun of Harvard and David Baulcombe of Cambridge University), the 2007 Medical Foundation Basic Science Award to David Lambright, Howard Hughes Medical Institute Investigator appointments to Michael Green, Roger Davis, and Craig Mello, and membership in the National Academy of Sciences (Mello and Ambros) and the Royal Society of London (Davis). Many other Molecular Medicine faculty have been recognized by awards for outstanding contributions in their fields of specialty, for example, a 2012 NIDA Avant Garde award to Jeremy Luban, the 2000 Banting Award to Michael Czech and the Elizabeth Glaser Scientist Award to Katherine Luzuriaga. Pew Scholar awards have been bestowed upon Tom Fazzio, Bert van den Berg and David Guertin..
The Program in Molecular Medicine offers within its building a broad spectrum of state-of-the-art methodologies to its laboratory groups including deep sequencing, ultrafast 3D digital imaging microscopy (wide field and TIRF) of live cells, spinning disc confocal microscopy, x-ray crystallography, mouse metabolic phenotyping, mouse knockout technology and RNAi-based gene silencing in vitro and in vivo. Medical School Core facilities also make available a large number of additional technologies such as FACS analysis, gene profiling using microarrays, proteomics and both shRNA and small molecule screening. Expertise in chemistry, structural biology, biochemistry, cell and developmental biology, molecular biology, cell signaling and regulation, genomics and proteomics, bioinformatics, genetics, immunology and virology is strongly represented in the Program in Molecular Medicine. Program faculty members are also active in the teaching of these disciplines in both core and advanced courses for graduate and medical students.
Structural biology at the UMass Medical School is supported by state-of-the-art X-ray and NMR core facilities housed in the Program in Molecular Medicine and the Department of Biochemistry and Molecular Pharmacology. Diffraction instrumentation includes three rotating anode X-ray generators equipped with R-axis IV, Mar 300 and Mar 350 image plates detectors, Osmic focusing mirrors, and nitrogen cryostreams. NMR instrumentation includes 400 MHz and 600 MHz Varian spectrometers equipped for multidimensional homonuclear and heteronuclear experiments. Computational resources include graphics workstations and multiprocessor Beowulf clusters for data processing, image reconstruction, 3D visualization, model building, refinement, molecular dynamics, and structural bioinformatics. Molecular Medicine laboratory groups utilize many model organisms in their research, including yeast, worms, flies, mice and nonhuman primates. Translational research on human subjects is also vigorously pursued with collaborators in clinical departments..
Faculty laboratory groups within the Program in Molecular Medicine are led by academic leaders in their respective fields of biology and medicine. The multidisciplinary nature of the Program has led to a significant number of collaborative publications by multiple laboratories. This is further enhanced by strong seminar and journal club activities as well as joint laboratory group meetings and consortium grants such as Keck and NIH-funded program projects. Based on its success in research and teaching, the Program attracts large numbers of graduate students, postdoctoral fellows and visiting scientists who in turn greatly enrich its scientific environment. .